Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of MDR-001 Administered Orally Over 52 Weeks in Participants With Overweight or Obesity (MOBILE)

NCT07274137 is registered in ClinicalTrials.gov with MindRank AI Ltd as lead sponsor.

NCT NCT07274137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of MDR-001 Administered Orally Over 52 Weeks in Participants With Overweight or Obesity (MOBILE)
Lead sponsor
MindRank AI Ltd
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
July 31, 2027
Enrollment
738 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

overweight or obesity